Search Results 601-610 of 18383 for total bilirubin

1. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

   Serum ALT/AST ≤ 2.5 x ULN; Total bilirubin ≤ 1.5 x ULN; Cardiac ejection fraction ≥ 50% and no clinically significant ECG findings; Baseline oxygen ...

2. A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma - Mayo Clinic

   - Total bilirubin ≤ 1.5 x ULN. - Creatinine clearance of ≥ 30 mL/min according to Cockcroft/Gault Formula Exclusion Criteria: - Prior treatment with an ...

3. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   total bilirubin >1.5 times upper normal limit (unless due to chronic GVHD) ... Adequate contraception is defined as hormonal birth control, intrauterine device, ...

4. MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer - Mayo Clinic

   Total bilirubin ≤ ULN;; AST ≤ 2 x ULN;; Creatinine ≤ 1.5 x ULN;; Hgb ≥ 9.0 g/dL. Willingness to return to Mayo Clinic Rochester or another participating ...

5. Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors - Mayo Clinic

   Total bilirubin ≤ 1.5 x ULN; if patient has known Gilbert's syndrome direct bilirubin ≤ 3.0 x ULN. Standard 12-lead electrocardiography (ECG) with the ...

6. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments - Mayo Clinic

   Total bilirubin < 1.5 mg/dL, ALT+ AST levels ≤ 3 times above the upper normal limit. The patient must have at least one measurable lesion and the relevant ...

7. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Aspartate aminotransferase (AST)/Alanine aminotransferase (ALT) ≤ 3.0 × upper limit of normal (ULN) and total bilirubin < 1.5 × ULN (or direct bilirubin < 1.5 ...

8. A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Serum M-protein ≥ 1 g/dL ( ≥10 g/L); Urine M-protein ≥ 200 mg/24 hours; Serum ... Total bilirubin ≤1.5 times the upper limit of the normal range (ULN) ...

9. A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

   Total bilirubin ≤ 1.5 x ULN (upper limit of normal);; Aspartate Aminotransferase (AST) ≤ 2.5 x ULN;; Serum Glutamic-Oxaloacetic Transaminase (SGOT) ≤ 2.5 x ...

10. A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Disease (PF-ILDs) - Mayo Clinic

    of normal (ULN) or total Bilirubin > 1.5 x ULN at Visit 1. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 9/1 ...